# Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness

> **NCT07305207** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Dalhousie University** · enrollment: 32 (estimated)

## Conditions studied

- Influenza (Healthy Volunteers)

## Interventions

- **BIOLOGICAL:** Intranasal inoculation of RG-A/Texas/71/2017 (H3N2) influenza in each naris on Day 1 of the study.

## Key facts

- **NCT ID:** NCT07305207
- **Lead sponsor:** Dalhousie University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-01-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-12-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305207, "Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07305207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*